Another interesting approach to Alzheimer's -- infection causing inflammation. Unfortunately the FDA won't let them continue with an open label extension study, because of liver toxicity concerns -- but it's good to see alternative ideas getting clinical trials.

https://endpts.com/cortexymes-unorthodox-alzh...-fda-hold/